Description
Emerging Technologies
Emerging Technologies The session brings together industrial case studies from practitioners who have delivered innovative solutions to enable the adoption of continuous processing within their companies.
- Commercializing New Chemical Technologies in Flow
Moiz Diwan, PhD, Director, Head of Enabling Technology Group
AbbVie
- Continuous Processing for the Manufacture of Active Pharmaceutical Ingredients
Martin Johnson, PhD, Sr. Engineering Advisor
Eli Lilly & Company
- The Use of Kinetic Modelling to Define a Design Space for a Continuous Process
Peter Shapland, PhD, Scientific Leader, R&D Medicinal Science & Technology
GSK Stevenage
Moderator(s):
- Malcolm
Berry,
PhD,
Continuous Chemistry Team Manager,
MB Chemistry Consulting, Ltd.
Speaker(s):
- Moiz
Diwan,
PhD,
Director, Pharmaceutical Development Research & Development,
AbbVie
- Martin
Johnson,
PhD,
Sr. Engineering Advisor,
Eli Lilly and Company
- Peter
Shapland,
PhD,
Scientific Leader, R&D Medicinal Science and Technology,
GSK Stevenage
